HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Blood

• Publication date

  2014-12-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2014-04-567065PMID 25267197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment

  2013cited by this paper
• HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.

  2013cited by this paper
• Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance.

  2013cited by this paper
• Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment

  2013cited by this paper
• A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice

  2013cited by this paper
• Hypoxia-inducible factors in physiology and medicine.

  2012cited by this paper
• HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

  2011cited by this paper
• HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

  2011cited by this paper
• Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

  2011cited by this paper
• Regulation of the HIF-1alpha level is essential for hematopoietic stem cells.

  2010cited by this paper
• HIF-2α deletion promotes Kras-driven lung tumor development

  2010cited by this paper
• The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.

  2010cited by this paper
• Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells.

  2008cited by this paper
• Hypoxia, HIF1 and glucose metabolism in the solid tumour

  2008cited by this paper
• Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region

  2007cited by this paper
• MLL translocations, histone modifications and leukaemia stem-cell development

  2007cited by this paper
• Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

  2007cited by this paper
• Efficient method to generate single‐copy transgenic mice by site‐specific integration in embryonic stem cells

  2006cited by this paper
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

  2006influential reference
• Genetic evidence for a tumor suppressor role of HIF-2alpha.

  2005cited by this paper
• Hematopoietic, angiogenic and eye defects in Meis1 mutant animals

  2004cited by this paper
• Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.

  2004cited by this paper
• Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

  2004cited by this paper
• Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.

  2004cited by this paper
• Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth

  2003cited by this paper
• Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

  2003cited by this paper
• Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3α Locus*

  2002cited by this paper
• BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

  2002cited by this paper
• The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma.

  2002cited by this paper
• Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches.

  2001cited by this paper
• Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth

  2000cited by this paper
• MEIS1 and HOXA7 genes in human acute myeloid leukemia.

  2000cited by this paper
• Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

  2000cited by this paper
• Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells

  1999cited by this paper
• Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias

  1999cited by this paper
• Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b

  1998cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Inducible gene targeting in mice

  1995cited by this paper
• A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

  1992cited by this paper

• Role of hypoxia factors in the transcriptional mechanisms of clonal hematopoiesis in myelodysplastic syndrome

  2025cites this paper
• Computational Analysis of Iron-binding Proteins in the Mutational Landscape of Cancer.

  2025cites this paper
• The hypoxia signaling pathway in the development of acute myeloid leukemia.

  2025cites this paper
• Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism

  2025cites this paper
• Differential effects of hypoxia on motility using various in vitro models of lung adenocarcinoma

  2024cites this paper
• The miR-199a-5p/HIF1α dual-regulatory axis participates in hypoxia-induced aggressive phenotypes of oral squamous cell carcinoma (OSCC) cells

  2024cites this paper
• The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia

  2024influential citation
• The role of gene expression hypoxia-inducible factor-1a and serum level monocyte chemoattractant protein-1 in the incidence of chronic myeloid leukemia in Iraqi patients

  2024cites this paper
• Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

  2024cites this paper
• A reductionist perspective on HIF-1α's role in cell proliferation under non-hypoxic conditions.

  2024cites this paper
• Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity

  2024cites this paper
• Survival impact of hypoxia-inducible factor-1 alpha (HIF-1α) in Nucleophosmin1 mutated acute myeloid leukemia

  2024cites this paper
• Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation

  2024cites this paper
• PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K/AKT/mTOR pathway through downregulation of GBE1.

  2024cites this paper
• The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia

  2023cites this paper
• The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma

  2023cites this paper
• von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology.

  2023cites this paper
• An antioxidant response element regulates the HIF1α axis in breast cancer cells.

  2023cites this paper
• HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

  2023cites this paper
• Metabolic crosstalk between stromal and malignant cells in the bone marrow niche

  2023cites this paper
• A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia.

  2023cites this paper
• A somatic mutation in moesin drives progression into acute myeloid leukemia

  2022cites this paper
• CD133(+)HIF-1α(−) Expression After Chemoradiotherapy Predicts Poor Prognosis in Rectal Cancer

  2022cites this paper
• Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy

  2022cites this paper
• Hypoxia and Hematopoiesis

  2022cites this paper
• Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice

  2022cites this paper
• The function and clinical implication of circular RNAs in lung cancer

  2022cites this paper
• Hypoxic stress and hypoxia-inducible factors in leukemias

  2022cites this paper
• HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System

  2022cites this paper
• Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

  2021cites this paper
• Therapeutic Targeting of the Leukaemia Microenvironment

  2021cites this paper
• Up-down regulation of HIF-1α in cancer progression.

  2021cites this paper
• Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia

  2021cites this paper
• Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter

  2021cites this paper
• Bone marrow niches in myelodysplastic syndromes

  2021cites this paper
• Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities

  2021cites this paper
• Mitochondrial Effects on Seeds of Cancer Survival in Leukemia

  2021cites this paper
• Meis1, Hi1α, and GATA1 are integrated into a hierarchical regulatory network to mediate primitive erythropoiesis

  2021cites this paper
• Breakthrough Science: Hypoxia-Inducible Factors, Oxygen Sensing, and Disorders of Hematopoiesis.

  2021cites this paper
• Whole transcriptome sequencing and integrated network analysis elucidates the effects of 3,8-Di-O-methylellagic acid 2-O-glucoside derived from Sanguisorba offcinalis L., a novel differentiation inducer on erythroleukemia cells.

  2021cites this paper
• NAD+ metabolism controls growth inhibition by HIF1 in normoxia and determines differential sensitivity of normal and cancer cells

  2021cites this paper
• Bone marrow niches in haematological malignancies

  2020cites this paper
• Circular RNAs in the tumour microenvironment

  2020cites this paper
• Location First: Targeting Acute Myeloid Leukemia Within Its Niche

  2020cites this paper
• Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.

  2020cites this paper
• CircRNAs in lung cancer - Biogenesis, function and clinical implication.

  2020cites this paper
• Cycling hypoxia selects for constitutive HIF stabilization

  2020cites this paper
• Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group

  2020cites this paper
• Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis

  2019cites this paper
• Triangle collaboration assessment of autophagy, ER stress and hypoxia in leukemogenesis: a bright perspective on the molecular recognition of B-ALL

  2019cites this paper
• ARv 7 Represses Tumor-Su ppressor Genes in Castration-Resistant Prostate Cancer Graphical

  2019cites this paper
• S2 File: Methods for Sample Clustering Case Study

  2019cites this paper
• Hypoxia-Inducible Factor 1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients

  2019cites this paper
• ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.

  2019cites this paper
• HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells

  2019cites this paper
• Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression.

  2019cites this paper
• HIF-α factors as potential therapeutic targets in leukemia

  2018cites this paper
• Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML

  2018cites this paper
• The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought

  2018cites this paper
• Altered susceptibility to apoptosis and N‑glycan profiles of hematopoietic KG1a cells following co‑culture with bone marrow‑derived stromal cells under hypoxic conditions.

  2018cites this paper
• Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia

  2018cites this paper
• Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target

  2018cites this paper
• Hypoxia Signaling Pathway in Stem Cell Regulation: Good and Evil

  2018cites this paper
• HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

  2018cites this paper
• Fumarate hydratase is a critical metabolic regulator of haematopoietic stem cell functions

  2017cites this paper
• miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism.

  2017cites this paper
• The hypoxia signalling pathway in haematological malignancies

  2017cites this paper
• MYELOID NEOPLASIA miR-125 b promotes MLL-AF 9 – driven murine acute myeloid leukemia involving a VEGFA-mediated non – cell-intrinsic mechanism

  2017cites this paper
• Leukemia Stem Cells Microenvironment.

  2017cites this paper
• Myeloid malignancies and the microenvironment.

  2017cites this paper
• HIF-1 in cancer therapy: two decade long story of a transcription factor

  2017cites this paper
• Fumarate hydratase is a critical metabolic regulator of haematopoietic stem cell functions

  2017cites this paper
• Exploring the role of GATA2 in normal and malignant haematopoiesis

  2017cites this paper
• IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1α.

  2017cites this paper
• Cancer metabolism: a therapeutic perspective

  2017cites this paper
• Integration of hypoxic HIF-α signaling in blood cancers

  2017cites this paper
• Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells

  2017cites this paper
• Combination of betulinic acid and chidamide inhibits acute myeloid leukemia by suppression of the HIF1α pathway and generation of reactive oxygen species

  2017cites this paper
• The Biology of Hematopoietic Stem Cells: transgenic approaches to Dissect Native and Perturbed Hematopoiesis

  2017cites this paper
• Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions

  2017cites this paper
• Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells.

  2017cites this paper
• BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine

  2016cites this paper
• Cell intrinsic and extrinsic regulation of leukemia cell metabolism

  2016cites this paper
• Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact

  2016cites this paper
• Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis

  2016cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Leukemias

  2016cites this paper
• Does hypoxia play a role in infantile hemangioma?

  2016cites this paper
• Hypoxia inducible factor-1α regulates a pro-invasive phenotype in acute monocytic leukemia

  2016cites this paper
• HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia

  2016cites this paper
• Oxidative stress and hypoxia in normal and leukemic stem cells.

  2016cites this paper
• Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?

  2016cites this paper
• Adult Hematopoietic Stem Cells: Niche Cross-Talks to Affect the Cell Fate

  2016cites this paper
• Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia

  2015cites this paper
• WNT16-expressing Acute Lymphoblastic Leukemia Cells are Sensitive to Autophagy Inhibitors after ER Stress Induction.

  2015cites this paper
• Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance

  2015influential citation
• MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.

  2015cites this paper
• Hypoxia regulates proliferation of acute myeloid leukemia and sensitivity against chemotherapy.

  2015cites this paper
• Hypoxia-inducible factors in cancer stem cells and inflammation.

  2015cites this paper
• Targeting HIF function: the debate continues.

  2014cites this paper
• Dual effect of oxidative stress on leukemia cancer induction and treatment

  2014cites this paper